[ADM] Archer-Daniels-Midland Thesis 2026: Nutrition Restatement Aftermath Tests Agribusiness Cycle Recovery
Key Takeaways
- FY2025 revenue ~$84-86B (-3 to -1% YoY) with adj. EPS ~$3.80-4.20 — Archer-Daniels-Midland Company is the leading global agribusiness firm focused on Ag Services & Oilseeds (~62% revenue) + Carbohydrate Solutions (~24%) + Nutrition (~12%; selected post-January 2024 accounting restatement scandal) + Other Business (~2%). FY2025 reflects continued post-2022-2023 commodity cycle moderation (selected post-Russia/Ukraine grain price normalization + selected ethanol margin compression + selected oilseed crush margin normalization) + continued post-January 22, 2024 accounting restatement aftermath (Nutrition segment intersegment sales SEC investigation + selected ~$200M+ restatement adjustments) + selected operational excellence under continued CEO Juan Luciano.
- January 22, 2024 Accounting Restatement Scandal — ADM disclosed January 22, 2024 that it would delay Q4 2023 earnings release amid SEC investigation into intersegment sales accounting practices in the Nutrition segment; CFO Vikram Luthar placed on administrative leave (subsequently resigned); company restated 2018-2023 financials with selected ~$200M+ cumulative adjustments to Nutrition segment operating profit (selected intersegment transfer pricing inflated Nutrition margins; selected actual Nutrition organic margins materially lower than originally reported); selected ongoing SEC investigation + selected DOJ inquiry + selected shareholder litigation; impacted FY2024 stock price (~25-30% decline post-disclosure).
- CEO Juan Luciano since January 2015 (~10-year tenure) — Luciano succeeded Patricia Woertz (CEO 2006-January 2015 retired). Luciano background: ex-ADM President + COO 2014-2015 + ex-Dow Chemical Performance Materials EVP 2009-2011 + ex-Dow Chemical Plastics various roles + ~30-year industrial chemicals + commodities executive career; selected operational + commodities heritage. Luciano's tenure has executed: 2015 CEO transition + 2015-2019 selected portfolio reshaping (selected Wild Flavors 2014 $3B + selected Neovia 2019 $1.85B + selected) + 2020 COVID disruption + recovery + 2022 Russia/Ukraine commodity boom (record FY2022 EPS $7.85) + 2022-2023 selected commodity cycle normalization + January 22, 2024 Nutrition restatement disclosure + selected restatement remediation + selected continued operational excellence + selected post-2024 capital return continuity. Capital return: dividend $2.00-2.04/share annual (~50 consecutive year increases — Dividend King 50+) + buybacks $0.5-1.5B; investment-grade A2/A credit rating.
- FY2026 thesis: Nutrition restatement aftermath resolution + agribusiness cycle recovery + capital return + dividend King continuity — Continued post-January 2024 Nutrition restatement aftermath resolution (selected SEC settlement + selected DOJ closure + selected shareholder litigation resolution) + selected agribusiness cycle recovery (selected ethanol + oilseed crush margin recovery) + selected operational excellence + selected dividend King continuity. Key risks: agribusiness commodity cyclicality (selected grain + selected oilseed + selected ethanol margins), continued SEC/DOJ investigation findings (selected enforcement action risk), tariff/trade exposure (US-China + Brazilian competition), selected weather/agricultural cycle.
Company Background
Archer-Daniels-Midland Company (NYSE: ADM), founded 1902 by John W. Daniels in Minneapolis Minnesota originally as Daniels Linseed Company (later merged with Archer-Daniels Linseed Company 1923 to form Archer-Daniels-Midland Company; IPO 1924), is the leading global agribusiness firm. Headquartered in Chicago, Illinois (corporate HQ moved from Decatur Illinois 2014; substantial Decatur + Chicago + selected operations), ADM operates ~38,000+ employees across selected ~200+ countries with ~$84-86B revenue. ADM's competitive moat rests on three structural advantages: (1) selected agribusiness scale leadership — ADM + Bunge + Cargill + Louis Dreyfus (ABCD) collectively control ~70%+ of global grain trading + oilseed crushing + selected ag services; ADM's scale provides selected origination + selected transportation + selected processing dominance; (2) selected vertical integration — selected upstream origination + midstream transportation + downstream processing + selected branded ingredient creates selected operational complexity moat; (3) selected dividend King heritage — ~50 consecutive year dividend increases provides selected income-oriented investor base + selected discipline; selected longest agribusiness sector dividend track.
CEO Juan Luciano took CEO role January 1, 2015 (succeeded Patricia Woertz CEO 2006-January 2015 who retired). Luciano's background:
- ADM President + COO (2014-2015)
- Dow Chemical Performance Materials EVP (2009-2011)
- Dow Chemical Plastics various roles (1985-2009)
- ~30-year industrial chemicals + commodities executive career
- Argentine national; selected commercial + operational heritage
Luciano's tenure has executed:
- January 2015 CEO Transition: succession from Woertz to Luciano
- 2015-2019 Portfolio Reshaping: selected Wild Flavors 2014 $3B + selected Neovia 2019 $1.85B (both Nutrition expansion) + selected divestments
- 2020 COVID Disruption + Recovery: selected operational resilience
- 2022 Russia/Ukraine Commodity Boom: record FY2022 adj. EPS $7.85 + record revenue
- 2022-2023 Commodity Cycle Normalization: selected post-spike adjustment
- January 22, 2024 Nutrition Restatement Disclosure: ADM delayed Q4 2023 earnings release amid SEC investigation into Nutrition segment intersegment sales accounting; CFO Vikram Luthar placed on leave (resigned later); selected ~$200M+ cumulative restatement adjustments
- March 2024 Restated Financials: 10-K/A filed with selected restated 2018-2023 Nutrition segment results
- 2024-2025 Restatement Aftermath: continued SEC investigation + selected DOJ inquiry + selected shareholder litigation
- 2024-2025 Continued Discipline: continued operational excellence + selected commodity cycle navigation + selected dividend continuity
Luciano's strategic positioning emphasizes:
- Nutrition restatement aftermath resolution
- Selected agribusiness cycle navigation
- Selected operational excellence + selected efficiency
- Selected portfolio simplification (selected non-core divestments)
- Capital return discipline (Dividend King continuity + buybacks)
Business Structure
ADM reports operations across 3 segments + Other:
1. Ag Services & Oilseeds — selected ~$53B FY2025 (~62% of revenue):
- Origination: selected grain trading + selected sourcing
- Crushing: selected oilseed (soybean + canola + sunflower) processing
- Refined Products & Other: selected refined oils + selected biodiesel
- Selected ~$2.5-3.0B segment operating profit
- Operating margin variable (~5-6%)
2. Carbohydrate Solutions — selected ~$20B FY2025 (~24% of revenue):
- Starches & Sweeteners: HFCS + glucose syrups + sweeteners
- Vantage Corn Processors: ethanol + selected industrial corn products
- Selected ~$0.8-1.0B segment operating profit
- Operating margin variable (~4-5%)
3. Nutrition — selected ~$10B FY2025 (~12% of revenue):
- Human Nutrition: selected ingredient blends + selected flavor solutions + selected
- Animal Nutrition: selected animal feed ingredients
- Selected post-2014 Wild Flavors $3B + selected Neovia 2019 $1.85B acquisitions
- Selected ~$0.5-0.7B segment operating profit (post-restatement)
- Operating margin variable (~5-7%)
4. Other — selected ~$1B FY2025 (~2% of revenue):
- Selected
- Operating margin variable
Key Core Metrics
Financial Performance Summary
| Metric | FY2022 | FY2023 | FY2024 | FY2025E |
|---|---|---|---|---|
| Revenue ($B) | 101.6 | 93.9 | 85.5 | 84-86 |
| Adj. EPS ($) | 7.85 | 6.43 | 4.74 | 3.80-4.20 |
| Adj. operating margin (%) | 5.5 | 4.7 | 4.0 | 3.8-4.2 |
| Ag Services revenue ($B) | 64 | 60 | 54 | 52-54 |
| Carbohydrate Solutions ($B) | 17.5 | 17.0 | 19.5 | 19-20 |
| Nutrition revenue ($B) | 7.9 | 7.7 | 7.4 | 7-8 |
| Diluted shares (M) | 565 | 540 | 500 | 485 |
| Annual dividend/share ($) | 1.60 | 1.80 | 2.00 | 2.00-2.04 |
Capital Return Framework (FY2025)
| Component | Annual ($M) | Per Share ($) |
|---|---|---|
| Dividend | ~970 | 2.00-2.04 |
| Buybacks | ~500-1,500 | (~1-3%/yr share count reduction) |
| Total capital return | ~1,470-2,470 |
Market Evaluation
Archer-Daniels-Midland trades at ~12-14x forward earnings with ~3.5% dividend yield, reflecting agribusiness cyclical + post-restatement discount valuation framework where investors price near-term Nutrition restatement aftermath resolution + agribusiness cycle recovery + capital return into multiple. Bull case: continued Nutrition restatement aftermath resolution + selected agribusiness cycle recovery + selected operational excellence + selected aggressive capital return + selected Dividend King continuity. Bear case: agribusiness commodity cyclicality (selected grain + selected oilseed + selected ethanol margins), continued SEC/DOJ investigation findings (selected enforcement action risk + selected fines + selected reputational damage), tariff/trade exposure (US-China + Brazilian competition), selected weather/agricultural cycle.
Compared to peers: ADM vs Bunge (BG, similar ~$60B revenue + post-July 2025 Viterra ~$8.2B merger pending; selected merger creates ~$120B+ combined entity); ADM vs Cargill (private; much larger ~$160B revenue + dominant grain trading); ADM vs Louis Dreyfus (private; ~$60B revenue); ADM vs Tyson Foods (TSN, ~$53B revenue + protein focus); ADM vs CHS Inc (private cooperative; ~$45B revenue); ADM vs Ingredion (INGR, smaller ~$8B revenue + corn ingredients); ADM vs Darling Ingredients (DAR, smaller ~$6B revenue + rendering). ADM's agribusiness scale + vertical integration + ~50-year Dividend King track + post-restatement governance reset create structural competitive advantages despite Bunge-Viterra merger competitive pressure.
Nutrition Restatement + Agribusiness Cycle + Capital Return + Dividend King
The FY2026 thesis for Archer-Daniels-Midland centers on Nutrition restatement aftermath resolution + agribusiness cycle recovery + capital return + Dividend King continuity.
Nutrition Restatement Aftermath:
- January 22, 2024 disclosure of SEC investigation into Nutrition segment intersegment sales accounting practices
- CFO Vikram Luthar placed on administrative leave January 22, 2024 (resigned March 2024)
- ~$200M+ cumulative restatement adjustments to Nutrition segment operating profit (2018-2023)
- Selected ongoing SEC investigation + selected DOJ inquiry + selected shareholder litigation
- Selected ~$0.50-1.00 cumulative EPS restatement impact
- FY2026 expected: continued aftermath resolution + selected SEC settlement + selected DOJ closure
- Selected ~$50-200M potential SEC fine + selected legal costs $100-300M
Agribusiness Cycle Recovery:
- Ag Services & Oilseeds revenue ~$53B FY2025 (vs $64B FY2022 commodity peak)
- Selected ethanol margins ~$0.10-0.20/gallon FY2025 (vs $0.50+ peak; selected normalized)
- Selected oilseed crush margins ~$45-55/ton FY2025 (vs $90+ peak; selected normalized)
- Selected post-2022 Russia/Ukraine commodity normalization
- FY2026 expected: continued cycle recovery + selected modest margin uplift
Operational Excellence:
- Adj. operating margin ~3.8-4.2% FY2025 (vs 5.5% FY2022 peak)
- Selected SG&A discipline + selected efficiency
- Selected technology investment + selected
- FY2026 expected: adj. operating margin sustained 4-4.5%
Capital Return:
- Dividend $2.00-2.04/share FY2025 (~50 consecutive year increases — Dividend King)
- Dividend yield ~3.5%
- Buybacks $0.5-1.5B FY2025 (~1-3%/yr share count reduction)
- Total capital return $1.5-2.5B
- Net debt $5-7B
- Investment-grade A2/A
FY2026 Outlook:
- Revenue toward $85-87B FY2026 (+1-2% on selected commodity recovery)
- Adj. EPS toward $4.00-4.40 (+5-10% on operational excellence + selected restatement aftermath stabilization + selected buyback compounding)
- Adj. operating margin sustained 4-4.5%
- Capital return $1.5-2.5B
- Dividend toward $2.04-2.12/share (continued ~50-year King track)
- FY2027 outlook: revenue $86-89B (+1-3%), adj. EPS $4.30-4.80 (+5-10%), capital return $1.7-2.7B
Key Risks:
- Agribusiness commodity cyclicality (selected grain + selected oilseed + selected ethanol margins; ~$200-400M annual EBITDA impact per 5% commodity price decline)
- Continued SEC/DOJ investigation findings (selected enforcement action + selected ~$50-200M potential fines + selected reputational damage; ~$0.30-0.50 EPS sensitivity per $250M fine)
- Tariff/trade exposure (US-China retaliatory tariffs + selected Brazilian soybean competition)
- Selected weather/agricultural cycle (selected drought + selected
- Selected Bunge-Viterra merger competitive pressure (post-July 2025 ~$8.2B merger creates ~$120B+ combined entity; selected pricing pressure)
- Selected Nutrition segment restatement governance overhang
- Selected long-tenured Luciano succession transition risk (~10-year tenure)
- Selected dividend King track maintenance pressure (~50 years)
FY2026 Watch Items:
- Nutrition restatement aftermath resolution (SEC settlement + DOJ closure)
- Adj. operating margin (target 4-4.5%)
- Adj. EPS growth (target +5-10%)
- Agribusiness commodity cycle indicators (ethanol + crush margins)
- Capital return execution (target $1.5-2.5B)
- Dividend increase (~50-year King track)
- Bunge-Viterra merger competitive impact
Archer-Daniels-Midland Company's FY2026 thesis is Nutrition restatement aftermath resolution + agribusiness cycle recovery + capital return + Dividend King continuity. Validation: SEC settles + commodity recovers + dividend King sustains + capital return delivered = thesis intact. Failure mode: SEC enforcement severe + commodity cycle severe + Bunge-Viterra severe + tariff escalation severe = agribusiness scale Luciano cannot fully insulate against despite ~50-year King discipline.